期刊文献+

P—gP在膀胱癌细胞中的差异表达研究 被引量:2

Differential expression of P-gp in bladder cancer cell lines
原文传递
导出
摘要 目的研究P-糖蛋白(P.gP)在人膀胱癌耐阿霉素细胞株(pumc-91/ADM)及不耐药膀胱癌细胞株(pumc-91)中的差异表达。方法横断面研究,采用阿霉素浓度梯度诱导法从人膀胱移行细胞癌puree-91建立人膀胱癌多药耐药细胞系pumc-91/ADM,通过SYBRGreenI实时荧光定量PCR(qRT-PCR)检测pumc-91/ADM和pumc-91细胞株中P—gPmRNA的表达情况,利用蛋白免疫印迹法(WesternBlot)对两种细胞中P-gP蛋白的表达进行半定量分析,同时采用免疫细胞化学技术对两种细胞中P-gP蛋白的表达进行定位及半定量分析,实验数据均使用独立样本的t检验进行分析。结果qRT-PCR结果显示,与pumc-91细胞相比,P-gPmRNA在pumc-91/ADM细胞中的表达水平上调了约7.74倍(t=11.97,P〈0.05);利用Image J软件分析Westernblot条带光密度比值,P-gP蛋白在pumc-91/ADM中的表达量(1.393±0.328)明显高于pumc-91(0.953±0.250)(t=4.35,P〈0.05);通过免疫细胞化学染色发现,P-gP在两种细胞的胞膜和胞浆均有表达,且在pumc-91/ADM中的表达量明显高于pumc-91(t=11.41,P〈0.05),差异均有统计学意义。结论P-gP在人膀胱癌耐阿霉素细胞株(pumc-91/ADM)中表达水平比其在不耐药膀胱癌细胞株(pumc-91)中表达水平显著上调。 Objective The generation of drug resistance often leads to the failure of the bladder cancer chemotherapy. P-glycoprotein (P-gp) is an ATP-dependent drug efflux pump linked to development of muhidrug resistance in cancer cells. The laboratory has successfully established adriamycin-resistant human bladder cancer cell line (pumc-91/ADM) from its parental cell line (pumc-91). According to the drug resistant spectrum analysis, pumc-91/ADM cell line exhibited the characteristics of multi-drug resistance. However, the expression of P-gp in two cell lines was still unknown. In this paper, there was a comparison between pumc-91/ADM and puree-91 about the differential expression of P-gp. Methods To determine the expression and location of P-gp in pumc-91 and pumc-91/ADM, qRT-PCR, Western blot and immunocytochemistry were applied in the experiment, qRT-PCR was implemented to research the expression of P-gp mRNA in two cell lines (pumc-91/ADM and pumc-91 ). Western blot was adopted to investigate the expression of P-gp protein in pumc-91 and pumc-91/ADM cell lines. Immunocytochemistry technique was used to explore the cellular location of P-gp and affirm its expression in two cell lines visually. Student's t-test was employed for statistical analysis and P 〈 0.05 was considered statistically significant. Results qRT-PCR analysis revealed that the expression of P-gp mRNA was upregulated in drug-resistant cell line pumc-91/ ADM compared to parental cell line pumc-91. To normalize for differences in the amount of total RNA, GAPDH was selected as an endogenous RNA control. Compared with pumc-91, the expression of P-gp mRNA was upregulated 7.74 fold in pumc-91/ADM (t = 11.97, P 〈 0. 05 ). Consistent with the qRT-PCR result, Western blot confirmed the protein of P-gp expressed differentially in two cell lines. The expression of P-gp protein was significantly increased in pumc-91/ADM compared to pumc-91. According to the results, the differences between pumc-91 and pume-91/ADM had statistical significance (t = 4.35, P〈0.05). Immunocytochemical analysis results demonstrated that P-gp was not only located in cell membrane but also in cytoplasm of the two cell lines. The expression of P-gp in pumc-91/ADM increased distinctly. The difference was statistically significant ( t = 11.41, P 〈 0. 05 ). Conclusion Compared with pumc-91, the expression of P-gp in pumc-9l/ADM was significantly upregulated.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2015年第4期277-280,共4页 Chinese Journal of Laboratory Medicine
基金 北京市自然科学基金(7122086)
关键词 膀胱肿瘤 移行细胞 细胞系 肿瘤 P-糖蛋白 Urinary bladder neoplasms Carcinoma, transitional cell Cell line, tumor R Glycoprotein
  • 相关文献

参考文献14

  • 1Eid SY, E1-Readi MZ, Eldin EE, et al. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells [J]. Phytomedicine, 2013,21 ( 1 ) :47-61.
  • 2Shao SL, Sun YY, Li XY, et al. The reversion effect of the RNAi-silencing mdrl gene on muhidrug resistance of the leukemia cell HP9[J]. Cell Biol Int, 2008, 32(8) :893-898.
  • 3Komoto C, Nakamura T, Yamamori M, et al. Reversal effects of Ca2 + antagonists on muhidrug resistance via down-regulation of MDR1 mRNA[J]. Kobe J Med Sci, 2007, 53(6) :355-363.
  • 4Hour TC, Lai YL, Kucm C1, et al. Transcriptional up-regulation of SOD1 by CEBPD:a potential target for cisplatin resistant human urothelial carcinoma cells [ J ]. Biochem Pharmacol, 2010, 80 ( 3 ) :325-334.
  • 5Dong Y, Pan Q, Jiang L, et al. Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells[J]. Biochem Biophys Res Commun, 2014, 446( 1 ) :85-90.
  • 6Yu S, Meng Q, Hu H,et al. Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer[ J]. Int J Clin Exp Pathol, 2014,7 (9) :5538-5548.
  • 7张敏,靳胜,张曼.膀胱癌多药耐药细胞株Pumc-91/ADM的建立及其生物学特性评价[J].医学研究杂志,2009,38(1):70-72. 被引量:5
  • 8Meng Q, Lei T, Zhang M, et al. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis[J]. J Cancer Res Clin Oncot, 2013, 139(3) : 509-519.
  • 9Hu H, Meng Q, Lei T, et al. Nucleophosminl associated with drug resistance and recurrence of bladder cancer [ J ]. Clin Exp Med, 2014 Jun 13. [ Epub ahead of print].
  • 10Braiq S, Bischoff F, Abhari BA, et al. The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancer[ J ]. Biochem Phm'macol, 2014, 91 (2) : 157-167.

二级参考文献33

  • 1隋华,周利红,刘宣,殷佩浩,周宁,王炎,孙珏,范忠泽,李琦.COX-2介导MDR1/P-gp调控人结肠癌细胞多药耐药的研究[J].中国癌症杂志,2011,21(4):241-246. 被引量:11
  • 2arsen AK,Escargueil AE,Skladanomski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther,2000,85 ( 3 ) :217 - 229
  • 3Schneider E, Yamazaki H. Sinha, BK. et al. Buthionine sulphoximine - mediated sensitisation of etoposide - resistant human breast cancer MCF7 ceils overexpressing the multidrug resistance - associated protein involves increased drug accumulation. Br Jcancer, 1995,71:738 -743
  • 4SUI H, ZHOU S, WANG Y, et al. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Juu at Ser63/73 in colorectal cancer [ J ] . Carcinogenesis, 2011, 32(5): 667-675.
  • 5YU M, OCANA A, TANNOCK I F. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? [J]. Cancer Metastasis Rev, 2013, 32(1-2): 211-227.
  • 6FANG Y, XUE J L, SHEN Q, et al. miR-7 Inhibits tumor growth and metastasis by targeting the PI3K/Akt pathway inhepatocellular carcinoma [J]. Hepatology, 2012, 55(6): 1852-1862.
  • 7GUO H, GAO M, LU Y, et al. Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules [ J ] . Oncogene, 2013. doi: 10.1038/onc.2013.301.
  • 8SUI H, FAN Z Z, LI Q. Signal transduction pathways and transcriptional mechanisms of ABCB 1/Pgp-mediated multiple drug resistance in human cancer cells [ J ] . J Int Med Res, 2012, 40: 426-435.
  • 9FIGUEIREDO L L, PINTAO M C, OLIVEIRA L C, et al. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia [ J ] . Cytometry B Clin Cytom, 2008, 74(3): 163-168.
  • 10WARD A B, SZEWCZYK P, GRIMARD V, et al. Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain [ J ] . Proc Natl Acad Sci U S A, 2013, 110(33): 13386-13391.

共引文献54

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部